SCHEMBL209471

SCHEMBL209471

c1ccc(CN2CCNCC2)nc1

nearest known ligand 0.97

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.61
L3MBTL1 Q9Y468 2/20 0.61
ALOX15 P16050 1/20 0.61
TSHR P16473 1/20 0.61
CYP1A2 P05177 1/20 0.61
CYP2C19 P33261 1/20 0.61
KMT2A Q03164 1/20 0.61
CXCR4 P61073 5/20 0.56
KDM4E B2RXH2 4/20 0.55
SIGMAR1 Q99720 2/20 0.55
KDM5C P41229 1/20 0.54
KDM4C Q9H3R0 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
SLC6A4 P31645 1/20 0.54
DDB1 Q16531 1/20 0.53
CRBN Q96SW2 1/20 0.53
PLD1 Q13393 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17485679 1.00 ALDH1A1 (0.61) ALDH1A1L3MBTL1ALOX15TSHRCYP1A2
SCHEMBL4903097 1.00 ALDH1A1 (0.61) ALDH1A1L3MBTL1ALOX15TSHRCYP1A2
Piperazine SCHEMBL28106509 0.98 ALDH1A1 (0.60) ALDH1A1L3MBTL1ALOX15TSHRCYP1A2
Hydrochloric Acid SCHEMBL27587923 0.98 ALDH1A1 (0.60) ALDH1A1L3MBTL1ALOX15TSHRCYP1A2
Hydrochloric Acid SCHEMBL1899181 0.98 ALDH1A1 (0.60) ALDH1A1L3MBTL1ALOX15TSHRCYP1A2
SCHEMBL3432550 0.98 ALDH1A1 (0.60) ALDH1A1L3MBTL1ALOX15TSHRCYP1A2
SCHEMBL3387061 0.98 ALDH1A1 (0.60) ALDH1A1L3MBTL1ALOX15TSHRCYP1A2
Hydrochloric Acid SCHEMBL30163937 0.98 ALDH1A1 (0.60) ALDH1A1L3MBTL1ALOX15TSHRCYP1A2
SCHEMBL3383287 0.98 ALDH1A1 (0.60) ALDH1A1L3MBTL1ALOX15TSHRCYP1A2
Hydrochloric Acid SCHEMBL29250334 0.97 ALDH1A1 (0.58) ALDH1A1L3MBTL1ALOX15TSHRCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 408 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108623578-B Benzoxadiazole pH fluorescent probe, preparation method and application 湖南文理学院 2021-06-25 CN claimed
CN-107849012-A A kind of kinase inhibitor 重庆复创医药研究有限公司 2018-03-27 CN claimed
CN-104507950-B Thienopyrimidines 拜耳医药股份有限公司 2017-03-22 CN claimed
CN-103387830-B Chromium-ion ratio type fluorescence probe as well as preparation method and application thereof UNIV XIANGTAN 2015-01-14 CN claimed
US-20140273458-A1 Chemical Mechanical Planarization for Tungsten-Containing Substrates AIR PRODUCTS AND CHEMICALS, INC. (US) 2014-09-18 US claimed
EP-2779217-A2 Chemical mechanical planarization for tungsten-containing substrates AIR PRODUCTS AND CHEMICALS, INC. (US) 2014-09-17 EP claimed
EP-2024363-B1 N-OXIDES OF PYRIDYLMETHYLPIPERAZINE AND -PIPERIDINE DERIVATIVES ABBOTT HEALTHCARE PRODUCTS BV (NL) 2012-08-01 EP claimed
EP-1831206-B1 N-SUBSTITUTED BENZIMIDAZOLYL C-KIT INHIBITORS AND COMBINATORIAL BENZIMIDAZOLE LIBRARY OSI PHARM INC (US) 2011-08-24 EP claimed
CN-101432279-A N-oxides of pyridylmethylpiperazine and -piperidine derivatives SOLVAY PHARM BV (NL) 2009-05-13 CN claimed
EP-2024363-A1 N-OXIDES OF PYRIDYLMETHYLPIPERAZINE AND -PIPERIDINE DERIVATIVES Solvay Pharmaceuticals B.V. (NL) 2009-02-18 EP claimed
JP-2008521903-A 2008-06-26 JP claimed
CN-101193867-A N-substituted benzimidazolyl c-Kit inhibitors and combinatorial benzimidazole libraries OSI PHARM INC (US) 2008-06-04 CN claimed
US-20070275977-A1 N-OXIDES OF PYRIDYLMETHYL -PIPERAZINE AND -PIPERIDINE DERIVATIVES SOLVAY PHARMACEUTICALS B.V. (NL) 2007-11-29 US claimed
WO-2007128694-A1 N-OXIDES OF PYRIDYLMETHYLPIPERAZINE AND -PIPERIDINE DERIVATIVES SOLVAY PHARMACEUTICALS B.V. (NL) 2007-11-15 WO claimed
EP-1831206-A2 N-SUBSTITUTED BENZIMIDAZOLYL C-KIT INHIBITORS AND COMBINATORIAL BENZIMIDAZOLE LIBRARY OSI Pharmaceuticals, Inc. (US) 2007-09-12 EP claimed
WO-2006060381-A2 N-SUBSTITUTED BENZIMIDAZOLYL C-KIT INHIBITORS AND COMBINATORIAL BENZIMIDAZOLE LIBRARY OSI PHARMACEUTICALS, INC. (US) 2006-06-08 WO claimed
US-20060116402-A1 N-substituted benzimidazolyl c-Kit inhibitors and combinatorial benzimidazole library OSI PHARMACEUTICALS, INC. 2006-06-01 US claimed
WO-2026102212-A1 MACROCYCLIC MCL-1 INHIBITORS VANDERBILT UNIVERSITY (US) 2026-05-15 WO disclosed
US-4374990-A ANTIDEPRESSANTS HOECHST AKTIENGESELLSCHAFT (DE) 1983-02-22 US disclosed
US-4115569-A PARASITICIDES HOECHST AKTIENGESELLSCHAFT (DE) 1978-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275977-A1 N-OXIDES OF PYRIDYLMETHYL -PIPERAZINE AND -PIPERIDINE DERIVATIVES CHRM5, HTR5A, CHRNA5 ALDH1A1 2009/4885L3MBTL1 4586/4885ALOX15 1177/4885
US-20060116402-A1 N-substituted benzimidazolyl c-Kit inhibitors and combinatorial benzimidazole library KIT, CHUK, TNNI3K ALDH1A1 977/4885L3MBTL1 3442/4885ALOX15 3763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.